334 related articles for article (PubMed ID: 17698511)
1. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
2. Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging.
Nachon F; Asojo OA; Borgstahl GE; Masson P; Lockridge O
Biochemistry; 2005 Feb; 44(4):1154-62. PubMed ID: 15667209
[TBL] [Abstract][Full Text] [Related]
3. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.
Doorn JA; Schall M; Gage DA; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):73-80. PubMed ID: 11601883
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
6. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
[TBL] [Abstract][Full Text] [Related]
7. Structural approach to the aging of phosphylated cholinesterases.
Masson P; Nachon F; Lockridge O
Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153
[TBL] [Abstract][Full Text] [Related]
8. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.
Millard CB; Kryger G; Ordentlich A; Greenblatt HM; Harel M; Raves ML; Segall Y; Barak D; Shafferman A; Silman I; Sussman JL
Biochemistry; 1999 Jun; 38(22):7032-9. PubMed ID: 10353814
[TBL] [Abstract][Full Text] [Related]
10. Pressure and propylene carbonate denaturation of native and "aged" phosphorylated cholinesterase.
Masson P; Gouet P; Clery C
J Mol Biol; 1994 May; 238(3):466-78. PubMed ID: 8176737
[TBL] [Abstract][Full Text] [Related]
11. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
12. Structural and kinetic evidence of aging after organophosphate inhibition of human Cathepsin A.
Bouknight KD; Jurkouich KM; Compton JR; Khavrutskii IV; Guelta MA; Harvey SP; Legler PM
Biochem Pharmacol; 2020 Jul; 177():113980. PubMed ID: 32305437
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of AChE by single and simultaneous exposure to malathion and its degradation products.
Krstić D; Colović M; Krinulović K; Djurić D; Vasić V
Gen Physiol Biophys; 2007 Dec; 26(4):247-53. PubMed ID: 18281741
[TBL] [Abstract][Full Text] [Related]
15. A molecular probe for the highly selective chromogenic detection of DFP, a mimic of Sarin and Soman nerve agents.
Gotor R; Costero AM; Gil S; Parra M; Martínez-Máñez R; Sancenón F
Chemistry; 2011 Oct; 17(43):11994-7. PubMed ID: 21922586
[No Abstract] [Full Text] [Related]
16. Methamidophos, dichlorvos, O-methoate and diazinon pesticides used in Turkey make a covalent bond with butyrylcholinesterase detected by mass spectrometry.
Tacal O; Lockridge O
J Appl Toxicol; 2010 Jul; 30(5):469-75. PubMed ID: 20229498
[TBL] [Abstract][Full Text] [Related]
17. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
19. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
Tsuge K; Seto Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
[TBL] [Abstract][Full Text] [Related]
20. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
